03:32 PM EST, 12/13/2024 (MT Newswires) -- Health care stocks were edging higher late Friday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each adding 0.2%.
The iShares Biotechnology ETF (IBB) shed 0.8%.
In corporate news, Bicycle Therapeutics ( BCYC ) shares sank 31% after it said topline data from a phase 1/2 trial of zelenectide pevedotin plus Merck's (MRK) pembrolizumab showed a 60% overall response rate in first-line metastatic urothelial cancer, in-line with existing therapies.